What Is The Future Of Using Outcomes-Based Contracts Between Payers And Pharmaceutical Manufacturers To Gain Market Access For Advanced Oncologic And Biologic Agents?
Abstract
Authors
R Paglia J Blackham A Del Carlo J Schwartz EA Carter C Foy S Dyson T Areteou